Determination of therapeutic plasma concentrations of tetrabenazine and an active metabolite by high-performance liquid chromatography.
A reversed-phase high-performance liquid chromatographic method for the determination of tetrabenazine and a hydroxy metabolite in plasma is described. Tetrabenazine and the hydroxy metabolite are quantified as their dehydro derivatives using fluorescence detection. This method has been applied to the analysis of plasma samples from patients with Huntington's chorea and has been found to be sensitive, reliable and specific for tetrabenazine and the hydroxy metabolite. The plasma concentrations of tetrabenazine found in patients were lower than could be detected using previously published methods.
D002851:Chromatography, High Pressure Liquid / Q000379:methods; D006801:Humans; D006816:Huntington Disease / Q000097:blood / Q000188:drug therapy; D013747:Tetrabenazine / Q000097:blood* / Q000378:metabolism / Q000627:therapeutic use; D013997:Time Factors
D013747:Tetrabenazine